| 1 |
33176060 | Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity. | 2021 Feb |
1 |
| 2 |
34743814 | SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate. | 2021 Dec 15 |
1 |
| 3 |
29173042 | Antithrombin conformational modulation by D-myo-inositol 3,4,5,6-tetrakisphosphate (TMI), a novel scaffold for the development of antithrombotic agents. | 2018 Nov |
1 |
| 4 |
25483839 | Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain. | 2015 Sep |
1 |
| 5 |
25600805 | Heparin cofactor II is degraded by heparan sulfate and dextran sulfate. | 2015 Feb 20 |
2 |
| 6 |
22577146 | Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation. | 2012 Jun 29 |
2 |
| 7 |
23152789 | On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. | 2012 |
1 |
| 8 |
21041295 | Thrombin-dependent MMP-2 activity is regulated by heparan sulfate. | 2010 Dec 31 |
5 |
| 9 |
16087677 | Plasmin- and thrombin-accelerated shedding of syndecan-4 ectodomain generates cleavage sites at Lys(114)-Arg(115) and Lys(129)-Val(130) bonds. | 2005 Oct 14 |
1 |
| 10 |
16107334 | Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool. | 2005 Nov 11 |
1 |
| 11 |
10702706 | Protein-bound heparin/heparan sulfates in human adult and umbilical cord plasma. | 1999 |
1 |
| 12 |
9526950 | Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis. | 1997 Nov 1 |
2 |
| 13 |
8603018 | Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin. | 1996 Feb |
3 |
| 14 |
8792767 | Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II. | 1996 Sep |
1 |
| 15 |
8589216 | Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides. | 1995 Jul |
1 |
| 16 |
8154338 | Mechanisms for the anticoagulant effects of synthetic antithrombins. | 1993 |
3 |
| 17 |
8507869 | Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. | 1993 Jun 15 |
1 |
| 18 |
1612123 | Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase. | 1992 Jul |
2 |
| 19 |
1744977 | Anticoagulant heparin-like glycosaminoglycans on endothelial cell surface. | 1991 Oct |
2 |
| 20 |
2529852 | Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa. | 1989 Sep 1 |
3 |
| 21 |
2973155 | Neutralization of thrombin by antithrombin III in the presence of cultured human fibroblasts. | 1988 Jul 15 |
8 |
| 22 |
3793724 | Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells. | 1987 Jan 5 |
1 |
| 23 |
2436525 | Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides. | 1986 |
1 |
| 24 |
6235872 | Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. | 1984 Sep |
4 |